We are live on ! Find out more
CRMD icon

CorMedix
CRMD

33 hedge funds and large institutions have $6.34M invested in CorMedix in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

10% more funds holding

Funds holding: 30 → 33 (+3)

2.46% more ownership

Funds ownership: 2.53% → 4.99% (+2.5%)

11% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 9

24% less capital invested

Capital invested by funds: $8.39M → $6.34M (-$2.05M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $56K

Holders
33
Holders Change
+3
Holders Change %
+10%
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
9
Closed
3
Calls
–
Puts
$56K
Net Calls
-$56K
Net Calls Change
+$475K

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$2.9M
2
EM
Elliott Management
New York
+$1.82M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.37M
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$542K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$77.3K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$112K
2
Citadel Advisors
Citadel Advisors
Florida
-$43K
3
Simplex Trading
Simplex Trading
Illinois
-$40K
4
GLRA
Gerald L. Ray & Associates
Texas
-$21.9K
5
RJFSA
Raymond James Financial Services Advisors
Florida
-$21K

CRMD Hedge Fund Activity: Q2 2017 in Review

33 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q2 2017, worth a combined $6.34M — down 24% from $8.39M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CRMD positions and 3 closed out — a net gain of 3 holders — while 8 added to existing stakes and 9 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $2.9M. The largest seller was BlackRock, cutting an estimated $112K.

  • 33 institutional investors held CorMedix (CRMD) as of Q2 2017, up from 30 in Q1 2017.
  • Funds reported $6.34M of CorMedix stock for Q2 2017, down 24% quarter-over-quarter.
  • 6 funds opened new CorMedix positions in Q2 2017 and 3 closed out, a net change of +3 holders.
  • The largest CorMedix buyer in Q2 2017 was Sabby Management, an estimated $2.9M added.
  • The largest CorMedix seller in Q2 2017 was BlackRock, an estimated $112K sold.

Based on aggregated 13F filings for Q2 2017.